Disclaimer: The TipRanks Smart Score performance is based on backtested results. Backtested performance is not an indicator of future actual results. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. Backtested results are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. General assumptions include: XYZ firm would have been able to purchase the securities recommended by the model and the markets were sufficiently liquid to permit all trading. Changes in these assumptions may have a material impact on the backtested returns presented. Certain assumptions have been made for modeling purposes and are unlikely to be realized. No representations and warranties are made as to the reasonableness of the assumptions. This information is provided for illustrative purposes only. Backtested performance is developed with the benefit of hindsight and has inherent limitations. Specifically, backtested results do not reflect actual trading or the effect of material economic and market factors on the decision-making process. Since trades have not actually been executed, results may have under- or over-compensated for the impact, if any, of certain market factors, such as lack of liquidity, and may not reflect the impact that certain economic or market factors may have had on the decision-making process. Further, backtesting allows the security selection methodology to be adjusted until past returns are maximized. Actual performance may differ significantly from backtested performance. Backtested results are adjusted to reflect the reinvestment of dividends and other income and, except where otherwise indicated, are presented gross-of fees and do not include the effect of backtested transaction costs, management fees, performance fees or expenses, if applicable. Please note all regulatory considerations regarding the presentation of fees must be taken into account. No cash balance or cash flow is included in the calculation.
I am a seasoned financial expert with extensive experience in analyzing investment strategies and financial instruments. My background includes a deep understanding of backtesting methodologies, risk assessment, and market dynamics. I've been actively involved in the financial industry for several years, providing insights into investment strategies and helping individuals make informed decisions.
Now, let's delve into the content you've provided about the TipRanks Smart Score performance and the associated disclaimer. The passage highlights the use of backtested results as a basis for evaluating the performance of a strategy. Backtesting involves applying a model retroactively to historical data to assess how it would have performed in the past. However, it's crucial to note that backtested performance does not guarantee future actual results.
The disclaimer emphasizes that the results are reflective of a strategy that wasn't historically offered to investors. This implies that the performance is hypothetical and doesn't represent the actual returns achieved by any investor. The assumptions integral to the model, such as the ability to purchase recommended securities and market liquidity, play a pivotal role in the calculated backtested results. Changes in these assumptions can significantly impact the outcomes.
Furthermore, the disclaimer acknowledges the limitations of backtested results, including the lack of reflection on actual trading, the influence of market factors, and the potential for over-optimization of the security selection methodology. It explicitly states that actual performance may differ significantly from backtested performance.
The adjustments made to backtested results, such as the reinvestment of dividends and the presentation gross-of fees, are also highlighted. The passage underscores the importance of considering regulatory considerations when presenting fees.
In essence, the disclaimer serves as a cautionary note, urging readers to interpret backtested performance with care. It emphasizes the inherent limitations and potential disparities between historical results and future actual outcomes. Investors are reminded to be mindful of the assumptions made in the backtesting process and to understand that real-world market conditions may differ.
FAQs
Dividend Data
JNJ 's annual dividend is $4.76 per share. This is the total amount of dividends paid out to shareholders in a year. Johnson & Johnson's ( JNJ ) ex-dividend date is May 20, 2024 , which means that buyers purchasing shares on or after that date will not be eligible to receive the next dividend payment.
What is the dividend payout for JNJ? ›
Dividend Data
JNJ 's annual dividend is $4.76 per share. This is the total amount of dividends paid out to shareholders in a year. Johnson & Johnson's ( JNJ ) ex-dividend date is May 20, 2024 , which means that buyers purchasing shares on or after that date will not be eligible to receive the next dividend payment.
How can I know the ex-dividend date? ›
Existing shareholders of a company's stock receive notification, typically by mail, when the company declares a dividend payment. Included in the information, along with the amount of the dividend, the record date, and the payment date is the ex-dividend date.
What will JNJ stock be worth in 5 years? ›
Johnson & Johnson stock price stood at $147.91
According to the latest long-term forecast, Johnson & Johnson price will hit $150 by the middle of 2024 and then $200 by the end of 2027. Johnson & Johnson will rise to $250 within the year of 2029 and $300 in 2032.
Is JNJ a good buy now? ›
Average Price Target
Based on 12 Wall Street analysts offering 12 month price targets for Johnson & Johnson in the last 3 months. The average price target is $179.17 with a high forecast of $215.00 and a low forecast of $160.00. The average price target represents a 17.57% change from the last price of $152.39.
How much dividend will I get? ›
Dividing the stock's annual dividend amount by its current share price allows you to calculate a stock's dividend yield. For example, if a stock is trading at $50 per share, and the company pays a quarterly dividend of 20 cents per share. That company's dividend would be 80 cents.
Did Johnson and Johnson dividend increase? ›
New Brunswick, NJ (April 16, 2024) – Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a 4.2% increase in the quarterly dividend, from $1.19 per share to $1.24 per share, marking the 62nd year of consecutive increases.
Is it better to buy before or after ex-dividend date? ›
The stock price drops by the amount of the dividend on the ex-dividend date. Remember, the ex-dividend date is the day before the record date. If investors want to receive a stock's dividend, they have to buy shares of stock before the ex-dividend date.
Can you sell on ex-dividend date and still get dividend? ›
Another important note to consider: as long as you purchase a stock prior to the ex-dividend date, you can then sell the stock any time on or after the ex-dividend date and still receive the dividend. A common misconception is that investors need to hold the stock through the record date or pay date.
Should I sell before or after ex-dividend date? ›
You must have acquired your shares before the ex-dividend date in order to receive a dividend. If you acquired your shares on or after the ex-dividend date, the previous owner will receive the dividend. Sell your shares on or after the Ex-Dividend Date and you'll receive the dividend.
Is Johnson & Johnson stock a Buy, Sell or Hold? Johnson & Johnson stock has received a consensus rating of buy. The average rating score is Aaa and is based on 46 buy ratings, 32 hold ratings, and 1 sell ratings.
Is JNJ a buy or hold? ›
Johnson & Johnson - Hold
Its Value Score of B indicates it would be a good pick for value investors. The financial health and growth prospects of JNJ, demonstrate its potential to outperform the market. It currently has a Growth Score of D.
Is JNJ a good stock to hold? ›
In the last year, 24 stock analysts published opinions about JNJ-N. 16 analysts recommended to BUY the stock. 7 analysts recommended to SELL the stock.
Why not to invest in Johnson and Johnson? ›
Key Points. Johnson & Johnson is one of the top healthcare companies in the world, with a market cap of nearly $400 billion. The company, however, faces an uncertain future because of its unsettled talc lawsuits. The litigation could threaten its dividend and long-term growth prospects.
Why is JNJ down so much? ›
Key Takeaways. Johnson & Johnson shares slipped following the release of a first-quarter earnings report that included sales figures below estimates, but better-than-expected income. The company also increased its dividend, marking 62 straight years it has done so.
Why should I buy JNJ stock? ›
Reasons to buy Johnson & Johnson stock now
These days, J&J has just two operating segments that are both growing much faster than its old consumer health division used to. Last year, J&J reported pharmaceutical revenue that rose 7.2% year over year if you ignore rapidly evaporating sales of its COVID-19 vaccine.
What is a monthly dividend payout? ›
A dividend is a portion of a company's earnings that is paid to a shareholder. The most common type of dividend is a cash payout, but some companies will issue stock dividends. Dividends are typically issued quarterly but can also be disbursed monthly or annually.
When did JNJ stock split? ›
The most recent stock split occured on June 13th, 2001. One JNJ share bought prior to May 18th, 1970 would equal to 144 JNJ shares today.
What are the top dividend stocks? ›
15 Best Dividend Stocks to Buy for 2024
| Stock | Dividend yield |
|---|
| Pfizer Inc. (PFE) | 6.6% |
| Coca-Cola Co. (KO) | 3.3% |
| Johnson & Johnson (JNJ) | 3.4% |
| Prologis Inc. (PLD) | 3.7% |
11 more rows4 days ago
This year the Entrust dividend was distributed on Wednesday 20 September 2023. Does everyone get the same amount? All beneficiaries receive $334 plus $30 from Vector for each installation control point (ICP) on their power account/s.
